Tobias Veit

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Dynamics of SARS-CoV-2 shedding in the respiratory tract depends on the severity of disease in COVID-19 patients

Dieter Munker, Andreas Osterman, Hans Stubbe et al. · European Respiratory Journal · 2021 · 92 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +11

Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy

Carlo Mümmler, Dieter Munker, Michaela Barnikel et al. · The Journal of Allergy and Clinical Immunology In Practice · 2020 · 69 citations

Pharmacy, Immunology, Pharmacology +12

Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy

Gabriela Leuschner, Florian Stocker, Tobias Veit et al. · The Journal of Heart and Lung Transplantation · 2017 · 59 citations

Medicine, Surgery, Pulmonology +12

Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study

Tobias Veit, Michaela Barnikel, Alexander Crispin et al. · Respiratory Research · 2020 · 47 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17